GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Net Current Asset Value

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Net Current Asset Value : RM0.13 (As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Malaysian Genomics Resource Centre Bhd's net current asset value per share for the quarter that ended in Sep. 2023 was RM0.13.

The historical rank and industry rank for Malaysian Genomics Resource Centre Bhd's Net Current Asset Value or its related term are showing as below:

XKLS:0155' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.14   Med: 8.33   Max: 46
Current: 3.23

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Malaysian Genomics Resource Centre Bhd was 46.00. The lowest was 1.14. And the median was 8.33.

XKLS:0155's Price-to-Net-Current-Asset-Value is ranked better than
60.98% of 123 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.35 vs XKLS:0155: 3.23

Malaysian Genomics Resource Centre Bhd Net Current Asset Value Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Net Current Asset Value Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 -0.02 -0.07 - 0.09

Malaysian Genomics Resource Centre Bhd Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.19 0.22 0.20 0.13

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Net Current Asset Value

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Price-to-Net-Current-Asset-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Price-to-Net-Current-Asset-Value falls into.



Malaysian Genomics Resource Centre Bhd Net Current Asset Value Calculation

Malaysian Genomics Resource Centre Bhd's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jun. 2021 is calculated as

Net Current Asset Value Per Share(A: Jun. 2021 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(15.663-4.853-0-0)/118.51
=0.09

Malaysian Genomics Resource Centre Bhd's Net Current Asset Value (NCAV) per share for the quarter that ended in Sep. 2023 is calculated as

Net Current Asset Value Per Share(Q: Sep. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(23.792-4.163-1.384-0)/137.21
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Malaysian Genomics Resource Centre Bhd Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines